139 related articles for article (PubMed ID: 35963427)
1. In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay.
Brecklinghaus T; Albrecht W; Duda J; Kappenberg F; Gründler L; Edlund K; Marchan R; Ghallab A; Cadenas C; Rieck A; Vartak N; Tolosa L; Castell JV; Gardner I; Halilbasic E; Trauner M; Ullrich A; Zeigerer A; Demirci Turgunbayer Ö; Damm G; Seehofer D; Rahnenführer J; Hengstler JG
Toxicol Lett; 2022 Sep; 368():33-46. PubMed ID: 35963427
[TBL] [Abstract][Full Text] [Related]
2. Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations.
Albrecht W; Kappenberg F; Brecklinghaus T; Stoeber R; Marchan R; Zhang M; Ebbert K; Kirschner H; Grinberg M; Leist M; Moritz W; Cadenas C; Ghallab A; Reinders J; Vartak N; van Thriel C; Golka K; Tolosa L; Castell JV; Damm G; Seehofer D; Lampen A; Braeuning A; Buhrke T; Behr AC; Oberemm A; Gu X; Kittana N; van de Water B; Kreiling R; Fayyaz S; van Aerts L; Smedsrød B; Ellinger-Ziegelbauer H; Steger-Hartmann T; Gundert-Remy U; Zeigerer A; Ullrich A; Runge D; Lee SML; Schiergens TS; Kuepfer L; Aguayo-Orozco A; Sachinidis A; Edlund K; Gardner I; Rahnenführer J; Hengstler JG
Arch Toxicol; 2019 Jun; 93(6):1609-1637. PubMed ID: 31250071
[TBL] [Abstract][Full Text] [Related]
3. The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds.
Brecklinghaus T; Albrecht W; Kappenberg F; Duda J; Vartak N; Edlund K; Marchan R; Ghallab A; Cadenas C; Günther G; Leist M; Zhang M; Gardner I; Reinders J; Russel FG; Foster AJ; Williams DP; Damle-Vartak A; Grandits M; Ecker G; Kittana N; Rahnenführer J; Hengstler JG
Chem Biol Interact; 2022 Jan; 351():109728. PubMed ID: 34717914
[TBL] [Abstract][Full Text] [Related]
4. Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis.
McMillian MK; Grant ER; Zhong Z; Parker JB; Li L; Zivin RA; Burczynski ME; Johnson MD
In Vitr Mol Toxicol; 2001; 14(3):177-90. PubMed ID: 11846991
[TBL] [Abstract][Full Text] [Related]
5. Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modeling.
Li S; Yu Y; Bian X; Yao L; Li M; Lou YR; Yuan J; Lin HS; Liu L; Han B; Xiang X
Arch Toxicol; 2021 May; 95(5):1683-1701. PubMed ID: 33713150
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved.
Martínez-Sena T; Moro E; Moreno-Torres M; Quintás G; Hengstler J; Castell JV
Arch Toxicol; 2023 Jun; 97(6):1723-1738. PubMed ID: 37022445
[TBL] [Abstract][Full Text] [Related]
7. A human liver organoid screening platform for DILI risk prediction.
Zhang CJ; Meyer SR; O'Meara MJ; Huang S; Capeling MM; Ferrer-Torres D; Childs CJ; Spence JR; Fontana RJ; Sexton JZ
J Hepatol; 2023 May; 78(5):998-1006. PubMed ID: 36738840
[TBL] [Abstract][Full Text] [Related]
8. A high content screening assay to predict human drug-induced liver injury during drug discovery.
Persson M; Løye AF; Mow T; Hornberg JJ
J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
[TBL] [Abstract][Full Text] [Related]
9. Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro Assays.
Shah F; Leung L; Barton HA; Will Y; Rodrigues AD; Greene N; Aleo MD
Toxicol Sci; 2015 Oct; 147(2):500-14. PubMed ID: 26206150
[TBL] [Abstract][Full Text] [Related]
10. In vitro to in vivo extrapolation and high-content imaging for simultaneous characterization of chemically induced liver steatosis and markers of hepatotoxicity.
Müller FA; Stamou M; Englert FH; Frenzel O; Diedrich S; Suter-Dick L; Wambaugh JF; Sturla SJ
Arch Toxicol; 2023 Jun; 97(6):1701-1721. PubMed ID: 37046073
[TBL] [Abstract][Full Text] [Related]
11. A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model.
Chen M; Tung CW; Shi Q; Guo L; Shi L; Fang H; Borlak J; Tong W
Arch Toxicol; 2014 Jul; 88(7):1439-49. PubMed ID: 24958025
[TBL] [Abstract][Full Text] [Related]
12. In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury risk.
Norona LM; Fullerton A; Lawson C; Leung L; Brumm J; Kiyota T; Maher J; Khojasteh C; Proctor WR
Arch Toxicol; 2020 Sep; 94(9):3185-3200. PubMed ID: 32583097
[TBL] [Abstract][Full Text] [Related]
13. Busulfan induces steatosis in HepaRG cells but not in primary human hepatocytes: Possible explanations and implication for the prediction of drug-induced liver injury.
Allard J; Bucher S; Ferron PJ; Launay Y; Fromenty B
Fundam Clin Pharmacol; 2024 Feb; 38(1):152-167. PubMed ID: 37665028
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Potential Risk of Drugs to Induce Hepatotoxicity in Human-Relationships between Hepatic Steatosis Observed in Non-Clinical Toxicity Study and Hepatotoxicity in Humans.
Goda K; Kobayashi A; Takahashi A; Takahashi T; Saito K; Maekawa K; Saito Y; Sugai S
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417920
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
[TBL] [Abstract][Full Text] [Related]
16. Prediction of drug-induced liver injury and cardiotoxicity using chemical structure and in vitro assay data.
Ye L; Ngan DK; Xu T; Liu Z; Zhao J; Sakamuru S; Zhang L; Zhao T; Xia M; Simeonov A; Huang R
Toxicol Appl Pharmacol; 2022 Nov; 454():116250. PubMed ID: 36150479
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes.
Terelius Y; Figler RA; Marukian S; Collado MS; Lawson MJ; Mackey AJ; Manka D; Qualls CW; Blackman BR; Wamhoff BR; Dash A
Chem Biol Interact; 2016 Aug; 255():31-44. PubMed ID: 26626330
[TBL] [Abstract][Full Text] [Related]
18.
Mirahmad M; Sabourian R; Mahdavi M; Larijani B; Safavi M
Drug Metab Rev; 2022 May; 54(2):161-193. PubMed ID: 35403528
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.
Kawaguchi M; Nukaga T; Sekine S; Takemura A; Susukida T; Oeda S; Kodama A; Hirota M; Kouzuki H; Ito K
Toxicol Appl Pharmacol; 2020 May; 394():114958. PubMed ID: 32198022
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
